Better COVID Survival with PD and Home HD

Among 1,336 people whose kidneys failed between March, 2020 and January, 2021, 13.12% (n=178) contracted COVID-19. Of these, most (n=139) did standard in-center HD, and 33 (3.87%) died. On PD, 39 people developed COVID, and 1 (0.81%) died. On home HD, there were zero cases of COVID and no deaths. Five transplant patients developed COVID, with a mortality rate of 1.47%.

Read the abstract » | (added 2022-10-17)

Tags: Covid, Standard In center HD, PD, Mortality, Home HD, Home Hd And Covid, Transplant

Impact of Telemedicine on PD Technique Survival

Can telemedicine (TM) help people stay on PD longer? A prospective study conducted in 27 hospitals in China since 2016 enrolled 7,539 patients. Compared to matched patients in the non-TM group (60.9%), those in the TM group (39.1%) had significantly lower risks of severe fluid overload, inadequate solute clearance, non-infectious catheter complications, transfer to HD, and death.

Read the abstract » | (added 2022-09-13)

Tags: Telemedicine, PD, Technique Survival, Fluid Overload, Inadequate Solute Clearance, Non infectious Catheter Complications

In Which Countries Do People Stay on PD Longer?

The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) analyzed time on PD among 218 randomly chosen clinics and 7,121 patients in seven countries including the U.S. Median time on PD ranged from 1.7 years in the UK to 3.2 years in Japan and Thailand. PD mortality risk was higher in Thailand and the U.S., and infection was the leading cause of transfers to HD.

Read the abstract » | (added 2022-06-10)

Tags: Peritoneal Dialysis Outcomes And Practice Patterns Study, PDOPPS, PD, Mortality, Hemodialysis Transfer, Kidney Transplantation

Meta-analysis of Risk Factors for Encapsulating Peritoneal Sclerosis

In data from 10 studies of 12,595 people, risk factors for EPS included younger age for starting PD, higher transport rates, longer PD duration, longer peritonitis duration, and history of glomerulonephritis.

Read the abstract » | (added 2022-04-18)

Tags: EPS, PD, Higher Transport Rates, Duration, Glomerulonephritis, EPS Risk Factors

Glycemic Variability and Survival in People with Diabetes on PD

A Swedish study divided 325 people with diabetes on PD into seven groups based on glycemic variability. Using the lowest variability group as a reference point, survival was significantly better with less variability in blood sugar.

Read the abstract » | (added 2022-02-14)

Tags: Diabetes, PD, Glycemic Variability, Survival, Blood Sugar

What We Don’t Know About Insulin Dosing for PD or HD Can Hurt Us

After 60 years of dialysis, we have a good sense of how to adjust insulin doses for PD and HD, right? Wrong. Even though diabetes is the leading cause of kidney failure, a systematic review of 11 articles found little information about insulin management.

Read the abstract » | (added 2022-02-14)

Tags: Insulin Dose, PD, HD, Insulin Management

PD and Home HD in the U.S. vs. Canada

PD and home HD offer well-documented advantages and lower total costs in high-income countries. Both have seen growth in the US during the last decade, driven by payment changes and COVID-19—but US numbers still lag behind Canada and other countries.

Read the abstract » | (added 2022-01-14)

Tags: Peritoneal Dialysis, PD, Home Haemodialysis, HHD

Health-related Quality of Life Better on PD than Standard HD in Morocco City

Compared to 71 people using standard HD, 20 doing PD had significantly better physical and mental component scores and staff encouragement, and significantly lower burden of kidney disease scores.

Read the abstract » | (added 2021-11-12)

Tags: Standard HD, PD, Component Scores, Burden Of Kidney Disease Scores

Some Antihypertensive Meds Reduce GI Bleeds in PD

GI bleeding is more likely in people with CKD. A study of 734 people on PD were followed to see if use of an ACE-inhitor or angiotensin receptor blocker (ARB) would reduce the incidence. After an 8-year follow-up, those who were taking these meds had a significantly lower rate of GI bleeding.

Read the abstract » | (added 2021-11-12)

Tags: GI Bleeding, CKD, PD, ACE inhitor, Angiotensin Receptor Blocker

Outcomes of Incremental PD

A retrospective cohort study looked at 175 PD patients followed for about 2 years. Starting PD with a lower vs. higher dose was associated with better survival.

Read the abstract » | (added 2021-08-12)

Tags: Peritoneal Dialysis , PD, End stage Kidney Disease, Dialysate Volume, Survival